You are here
Press Releases: 2022
2022
The CEO Roundtable on Cancer is recognizing two companies and three universities for their commitment to the health of employees, students and community members with CEO Cancer Gold Standard™ accreditation.
MD Anderson received the 2022 Charles A. Sanders Life Sciences Award at the CEO Roundtable’s Annual Meeting and Conference on Nov. 1. Merck and Dr. Granger each were honored with the Spirit of Health Award.
Three new companies have earned CEO Cancer Gold Standard accreditation from the CEO Roundtable on Cancer, recognizing their focus on building a healthier workplace by focusing on cancer risk reduction, early detection, access to clinical trials, and high-quality care.
Five new companies have joined the CEO Roundtable on Cancer and its campaign to do something more about cancer prevention, diagnosis, and treatment for their employees, their families, and their communities.
The CEO Roundtable on Cancer (CEORT) Board of Directors today announced that William C. Louv, PhD, will lead the organization as Chief Executive Officer effective immediately, and it has elected two new Directors: David M. Reese, MD, Executive Vice President of R&D at Amgen, and Major General Elder Granger, MD, President and CEO of THE 5Ps, LLC.
Charles A. Sanders Award presented to Amgen and CEO Robert A. Bradway and former Glaxo Wellcome CEO Robert A. Ingram;.Spirit of Health Award goes to B&C Associates Inc. Founder and CEO Robert J. Brown.
Collaboration with HBCUs, HSIs, Merck, Amgen and SAS Elevates Cancer Prevention, Diagnosis, Quality Treatment Addressing Disparities in Health